MASS 908 Devices Inc.
Laboratory Analytical Instruments · Nasdaq · SEC CIK 1555279 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY23.7%
TTM net income YoY-487.1%
TTM EPS YoY-384.6%
Revenue 3-yr CAGR11.5%
Net income 3-yr CAGR—
Margins
Gross margin52.3%
Operating margin-42.7%
Net margin-36.9%
FCF margin4.0%
EBITDA margin-34.9%
Returns
ROE-17.0%
ROA-12.4%
ROIC (approx.)-27.8%
Asset turnover0.34x
Leverage & solvency
Liabilities / assets24.9%
Debt / equity0.00x
Current ratio5.43x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.12x
Accruals ratio-13.9%
Payout ratio—
Capex / revenue0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $18.95M | $16.07M | $13.38M | $17.38M | $14.01M | $13.04M | $11.78M | $14.34M |
| Cost of revenue | $8.93M | $7.73M | $6.50M | $8.23M | $6.65M | $6.66M | $6.24M | $7.67M |
| Gross profit | $10.02M | $8.34M | $6.88M | $9.15M | $7.36M | $6.37M | $5.54M | $6.67M |
| R&D expense | $3.82M | $3.60M | $3.47M | $3.50M | $3.84M | $4.41M | $3.83M | $3.90M |
| SG&A expense | $11.98M | $11.11M | $9.91M | $8.82M | $9.13M | $10.34M | $10.24M | $10.46M |
| Operating income | -$5.48M | -$12.81M | -$12.88M | $3.09M | -$16.32M | -$15.16M | -$11.03M | -$16.75M |
| Pretax income | -$4.63M | -$11.95M | — | $4.21M | -$14.88M | -$12.84M | — | -$16.02M |
| Income tax | -$50,000 | -$54,000 | — | -$166,000 | $29,000 | $71,000 | — | -$71,000 |
| Net income | -$4.58M | -$11.89M | -$11.96M | $4.17M | -$14.98M | -$13.31M | $43.60M | -$19.45M |
| EBITDA | -$3.98M | -$11.45M | -$11.74M | $4.20M | -$15.92M | -$14.19M | -$9.73M | -$15.31M |
| EPS (basic) | -0.11 | -0.32 | -0.32 | — | -0.41 | -0.37 | 1.23 | — |
| EPS (diluted) | -0.11 | -0.32 | -0.32 | — | -0.41 | -0.37 | 1.23 | — |
| Weighted avg. shares (diluted) | 41.07M | 37.73M | 36.82M | — | 36.10M | 35.88M | 35.39M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $63.61M | $63.02M | $67.56M | $70.52M | $62.80M | $61.75M | $79.16M | $44.20M |
| Short-term investments | $35.51M | $38.51M | $44.18M | $42.45M | $49.25M | $56.83M | $45.15M | $25.57M |
| Receivables | $17.22M | $11.71M | $9.87M | $11.33M | $11.00M | $6.21M | $6.93M | $8.85M |
| Inventory | $14.69M | $14.37M | $13.24M | $12.99M | $15.33M | $15.46M | $12.74M | $10.89M |
| Current assets | $135.15M | $132.02M | $142.01M | $144.56M | $144.94M | $147.87M | $149.00M | $103.06M |
| PP&E, net | $4.44M | $4.61M | $4.14M | $4.23M | $4.15M | $1.65M | $1.51M | $1.59M |
| Goodwill | $10.24M | $11.05M | — | $0 | — | — | — | $0 |
| Intangibles | $44.07M | $45.12M | $35.68M | $36.41M | $37.14M | $37.25M | $37.97M | $38.68M |
| Total assets | $199.36M | $197.54M | $186.69M | $190.07M | $190.87M | $191.70M | $196.03M | $159.48M |
| Current liabilities | $24.89M | $49.42M | $39.66M | $34.06M | $41.48M | $29.71M | $19.56M | $25.15M |
| Total liabilities | $49.55M | $70.77M | $52.52M | $46.37M | $54.57M | $42.88M | $36.60M | $44.88M |
| Shareholders' equity | $149.80M | $126.77M | $134.17M | $143.70M | $136.30M | $148.82M | $159.42M | $114.59M |
| Shares outstanding | 41.42M | 38.06M | 37.41M | 36.32M | 36.12M | 36.06M | 35.74M | 35.10M |
| Cash flow statement | ||||||||
| Operating cash flow | -$2.81M | $3.17M | $1.21M | $1.32M | -$4.20M | -$5.78M | -$15.02M | -$2.24M |
| Capital expenditure | $65,000 | $162,000 | $40,000 | -$6,000 | $680,000 | $122,000 | $159,000 | $190,000 |
| Free cash flow | -$2.88M | $3.01M | $1.17M | $1.32M | -$4.88M | -$5.91M | -$15.18M | -$2.43M |
| Investing cash flow | $2.95M | -$7.32M | -$1.99M | $6.81M | $5.21M | -$11.59M | $50.31M | $780,000 |
| Financing cash flow | $512,000 | $965,000 | -$2.17M | -$414,000 | -$16,000 | -$78,000 | -$189,000 | $529,000 |
| Depreciation & amortization | $1.50M | $1.36M | $1.14M | $1.11M | $400,000 | $972,000 | $1.29M | $1.44M |
| Stock-based compensation | $2.34M | $2.31M | $2.40M | $2.77M | $2.38M | $2.34M | $2.37M | $2.83M |
Free plan shows the latest 8 periods; Pro shows all 27 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.